News

Compass Therapeutics Set to Share Financial Insights Soon

Compass Therapeutics Set to Share Financial Insights Soon

Compass Therapeutics Financial Results Update

Compass Therapeutics, Inc. (Nasdaq: CMPX), an innovative biopharmaceutical company specializing in oncology, is gearing up to share their financial results for the recent quarter concluding on June 30. They will host a comprehensive conference call along with a webcast to discuss the progress and future directions of their key clinical studies.

Conference Call and Webcast Details

The financial results presentation is set for Monday at 8:00 a.m. ET. This call will shed light on several significant developments, including the ongoing Phase 2/3 study of tovecimig, alongside clinical insights regarding CTX-8371 and preclinical findings involving CTX-10726.

How to Join the Call

To participate in the call, dial 1-877-407-9716 for callers in the US and 1-201-493-6779 for international participants. Attendees will need the conference ID: 13754954 to join. A replay of the call will be made available for an extended period of 90 days, providing ample opportunity for those who cannot attend live.

Webcast Link

For those interested in viewing the webcast, it can be accessed online. The link will lead to a platform where further information about the company's performance will be available.

About Compass Therapeutics

Founded in 2014 and based in Boston, Compass Therapeutics focuses on crafting antibody-based therapeutics aimed at addressing various oncological conditions. Their research aims to deepen the understanding of how angiogenesis and the immune system interact in tumor dynamics.

The company has developed a promising pipeline, targeting critical pathways fundamental to effective anti-tumor strategies. Their approach includes targeting microvascular systems through angiogenesis-intervening agents and enhancing immune responses through activators that stimulate tumor-fighting cells.

Compass is dedicated to advancing its unique product candidates into clinical settings, both as standalone treatments and in combination with their own pipeline developments, ensuring that they stay at the forefront of cancer therapeutics.

Investor Relations

For investor inquiries, stakeholders can reach out via email at ir@compasstherapeutics.com. Investors can expect regular updates and insights as the company progresses toward their goals.

Media Inquiries

Media can connect with Anna Gifford, the Chief of Staff at Compass Therapeutics, for any related questions. She is accessible at media@compasstherapeutics.com or by phone at 617-500-8099.

Frequently Asked Questions

What is the purpose of the upcoming conference call?

The conference call is designed to present Compass Therapeutics' financial results for the last quarter and discuss key developments in their clinical studies.

When will the conference call take place?

The call is scheduled for Monday at 8:00 a.m. ET.

How can I participate in the conference call?

Participants can dial 1-877-407-9716 in the US or 1-201-493-6779 internationally, using the conference ID 13754954.

What is the focus of Compass Therapeutics?

Compass Therapeutics is focused on developing proprietary antibody-based therapeutics for oncology, addressing angiogenesis and immune response in tumor growth.

Who should I contact for media inquiries?

Media inquiries can be directed to Anna Gifford at media@compasstherapeutics.com or by calling 617-500-8099.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 2

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 6

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Shift at Tourmaline Bio: CMO Resignation Announced

Updated Category News Views 119

Leadership Transition at Tourmaline Bio Tourmaline Bio, Inc. (NASDAQ:TRML) has recently revealed a significant change within its leadership. Dr. Yung Chyung, the Chief Medical Officer (CMO), is set to resign from his post effective at the end of October. This announcement took place in a recent filing, highlighting the company's commitment to transparency as it reshapes...

Continue Reading
Innovative Cancer Research by Compugen at Upcoming Conference

Updated Category News Views 118

Compugen to Showcase Groundbreaking Research in Cancer Immunotherapy Compugen Ltd. (Nasdaq: CGEN), a leading force in clinical-stage cancer immunotherapy, has announced an exciting opportunity to present at the upcoming Single Cell Genomics 2025 Conference. This event, scheduled for September 15-17, highlights advancements in genomics and how it intertwines with cancer...

Continue Reading
Transform Your Finances: The Journey of Salesforce Stock

Updated Category News Views 222

Transformational Growth of Salesforce Stock Over the past 15 years, Salesforce (NYSE: CRM) has emerged as a powerhouse in the tech industry, consistently surpassing market expectations. With an impressive average annual return rate of 22.25%, it has outperformed the broader market by 10.15% on an annualized basis. As of now, the company's market capitalization stands at...

Continue Reading
Infosys and AGCO Join Forces for Transformational Success

Updated Category News Views 185

Infosys and AGCO Team Up for IT and HR Transformation Building on a longstanding relationship to enhance AGCO's operational framework for growth by leveraging Infosys Cobalt and Infosys Topaz. Infosys (NSE: INFY), a global leader in next-generation digital services and consulting, has announced the continuation of its strategic partnership with AGCO Corporation (NYSE:...

Continue Reading
Transforming Europe's Contract Furniture Market with AI Strategies

Updated Category News Views 385

Growth of Europe's Contract Furniture Market The contract furniture and furnishing market in Europe is on the verge of a substantial transformation, anticipating an impressive growth of USD 4.75 billion from 2024 to 2028. The compound annual growth rate (CAGR) is expected to be close to 5.1% during this forecast period. This expansion is mainly driven by the increasing...

Continue Reading